The latest price target for Repare Therapeutics (NASDAQ:RPTX) was reported by LifeSci Capital on December 13, 2024. The analyst firm set a price target for $0.00 expecting RPTX to fall to within 12 months (a possible -100.00% downside). 11 analyst firms have reported ratings in the last year.

The latest analyst rating for Repare Therapeutics (NASDAQ:RPTX) was provided by LifeSci Capital, and Repare Therapeutics downgraded their market perform rating.

The last upgrade for Repare Therapeutics Inc happened on June 9, 2023 when Stifel raised their price target to $16. Stifel previously had a hold for Repare Therapeutics Inc.

The last downgrade for Repare Therapeutics Inc happened on December 13, 2024 when LifeSci Capital changed their price target from N/A to N/A for Repare Therapeutics Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Repare Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Repare Therapeutics was filed on December 13, 2024 so you should expect the next rating to be made available sometime around December 13, 2025.

While ratings are subjective and will change, the latest Repare Therapeutics (RPTX) rating was a downgraded with a price target of $0.00 to $0.00. The current price Repare Therapeutics (RPTX) is trading at is $1.36, which is out of the analyst’s predicted range.